Back
Emergent BioSolutions Vs. Garmin Industry Stock Comparison
Sell
49
EBS
Emergent BioSolutions
Last Price:
9.06
Seasonality Move:
6.33%
Buy
71
GRMN
Garmin
Last Price:
198.35
Seasonality Move:
4.43%
Sell
49
Emergent BioSolutions (EBS)
is a Sell
Is Emergent BioSolutions a Buy, Sell or Hold?
- The current Emergent BioSolutions [EBS] share price is $9.60. The Score for EBS is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- EBS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Garmin (GRMN)
is a Buy
Is Garmin a Buy, Sell or Hold?
- The current Garmin [GRMN] share price is $204.92. The Score for GRMN is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- GRMN is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EBS Stock Price Chart
What is Emergent BioSolutions's stock price today?
-
The Emergent BioSolutions share price today is $9.60
The current trend is moderately bullish and EBS is experiencing slight buying pressure.
EBS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.33 | Buy |
| Relative Strength Index (14 RSI): | 56.89 | Buy |
| Chaikin Money Flow: | 128443 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.99 - 9.69) | Buy |
| Bollinger Bands (100): | (6.68 - 10.72) | Buy |
GRMN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.06 | Buy |
| Relative Strength Index (14 RSI): | 81.76 | Buy |
| Chaikin Money Flow: | 2350776 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (160.79 - 177.51) | Buy |
| Bollinger Bands (100): | (162.52 - 177.74) | Buy |
EBS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.34 | Buy |
| 20-day SMA: | 9.17 | Buy |
| 50-day SMA: | 8.4 | Buy |
| 200-day SMA: | 5.81 | Buy |
| 8-day EMA: | 9.32 | Buy |
| 20-day EMA: | 9.01 | Buy |
| 50-day EMA: | 8.66 | Buy |
| 200-day EMA: | 7.1 | Buy |
GRMN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 169.1 | Buy |
| 20-day SMA: | 167.91 | Buy |
| 50-day SMA: | 173.55 | Buy |
| 200-day SMA: | 157.19 | Buy |
| 8-day EMA: | 173.78 | Buy |
| 20-day EMA: | 170.36 | Buy |
| 50-day EMA: | 170.76 | Buy |
| 200-day EMA: | 157.44 | Buy |
Emergent BioSolutions Earnings Growth & EBS Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.20 per share, and an increase next year of $4.66 per share.
Garmin Earnings Growth & GRMN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.66 per share, and an increase next year of $0.01 per share.
Emergent BioSolutions Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Garmin Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||